Pediatrix Medical Group, Inc. (NYSE:MD) Receives Average Recommendation of “Hold” from Analysts

Pediatrix Medical Group, Inc. (NYSE:MD) has earned a consensus recommendation of “Hold” from the six brokerages that are presently covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $22.50.

Several research firms have weighed in on MD. UBS Group boosted their price target on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 12th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Pediatrix Medical Group in a research note on Wednesday, June 24th. Truist Financial raised their price objective on Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a research note on Monday, April 13th. Mizuho set a $24.00 target price on Pediatrix Medical Group in a research note on Friday, May 8th. Finally, Jefferies Financial Group restated a “buy” rating and set a $27.00 target price on shares of Pediatrix Medical Group in a report on Monday, April 20th.

Pediatrix Medical Group Price Performance

Shares of MD stock traded down $0.67 during trading hours on Friday, hitting $26.25. 559,631 shares of the company’s stock were exchanged, compared to its average volume of 769,692. The company has a market capitalization of $2.16 billion, a PE ratio of 12.74 and a beta of 0.66. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45. Pediatrix Medical Group has a 12-month low of $11.84 and a 12-month high of $27.94. The business’s 50 day simple moving average is $23.58 and its 200-day simple moving average is $22.05.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The company had revenue of $476.20 million during the quarter, compared to analysts’ expectations of $465.83 million. During the same quarter in the prior year, the company earned $0.33 EPS. The firm’s revenue was up 3.9% on a year-over-year basis. On average, equities research analysts anticipate that Pediatrix Medical Group will post 2.1 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Shirley A. Weis sold 36,028 shares of Pediatrix Medical Group stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.80% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in MD. Wasatch Advisors LP bought a new stake in shares of Pediatrix Medical Group during the 1st quarter valued at about $43,861,000. Allspring Global Investments Holdings LLC bought a new position in Pediatrix Medical Group in the fourth quarter worth about $13,613,000. Rockefeller Capital Management L.P. raised its stake in Pediatrix Medical Group by 814.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 594,351 shares of the company’s stock worth $12,713,000 after buying an additional 529,367 shares in the last quarter. Ameriprise Financial Inc. lifted its holdings in Pediatrix Medical Group by 175.4% in the second quarter. Ameriprise Financial Inc. now owns 744,473 shares of the company’s stock worth $10,683,000 after buying an additional 474,186 shares during the period. Finally, BNP Paribas Financial Markets lifted its holdings in Pediatrix Medical Group by 669.4% in the second quarter. BNP Paribas Financial Markets now owns 476,098 shares of the company’s stock worth $6,832,000 after buying an additional 414,216 shares during the period. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.